Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Short Interest Update

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) was the target of a large decline in short interest in the month of May. As of May 29th, there was short interest totaling 118,738 shares, a decline of 33.8% from the May 14th total of 179,478 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Shin Nippon Biomedical Laboratories Stock Performance

Shares of Shin Nippon Biomedical Laboratories stock remained flat at $7.00 during trading on Wednesday. The stock has a 50 day moving average of $8.90 and a two-hundred day moving average of $9.60. Shin Nippon Biomedical Laboratories has a fifty-two week low of $7.00 and a fifty-two week high of $9.16.

Shin Nippon Biomedical Laboratories Company Profile

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.

The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.